Host Paul Raeburn interviews Dr. Steven Nissen, chair of cardiovascular medicine at the Cleveland Clinic, at the American College of Cardiology 2008 Conference in Chicago. Dr. Nissen shares his thoughts on results from the PERISCOPE study, which measured the comparative potential for cardiovascular benefits of an insulin secretion promoter, glimepiride, and insulin sensitizer, pioglitazone. The central question: Does it matter how you lower blood sugar?

ReachMD and VerusMed bring you Conference Coverage Highlights from the 30th Annual San Antonio Breast Cancer Symposium. This program was generously supported by The CBCE, leaders in oncology medical education. You will hear insights on the latest in breast cancer research.

What's good about the Federal/State Medicaid program, and how could it be improved? Tim Westmoreland, a lawyer and health care expert at the Georgetown University Health Law Institute in DC, discusses the problem of getting more people covered.